Search clinical trials for: 1% Diclofenac Sodium

Total 23738 results

Amneal Pharmaceuticals, LLC
Sristek Clinical Research Solutions Limited

Completed

Study Comparing a Generic Diclofenac Sodium Topical Gel, 1% to Voltaren in the Treatment of Subjects With Osteoarthritis of the Knee

Osteoarthritis

India
Mylan Pharmaceuticals Private Limited

Completed

A Bioequivalence Study Using Clinical Endpoint for Diclofenac Sodium Gel 1% in Osteoarthritis Knee"

Osteoarthritis, Knee

India
Rush University Medical Center

Recruiting

Aquacel Hypersensitivity Dressing in TJAs

Contact Allergic Dermatitis | Adverse Skin Reaction

United States
Noven Pharmaceuticals, Inc.

Completed

A 4-week Study to Evaluate the Efficacy and Safety of HP-5000 in Subjects With Knee Osteoarthritis (HP-5000)

Osteoarthritis of the Knee

United States
GlaxoSmithKline

Completed

A Multicenter Efficacy Study of a Diclofenac+Menthol Gel in Subjects With Ankle Sprain

Pain

Germany
Mallinckrodt

Completed

Pharmacokinetics, Bioavailability and Safety of PENNSAID® Gel

Pain

United States
University Hospital Rijeka

Completed

Diclophenac Versus Placebo for Pain Control in Diagnostic Colonoscopy

Anemia

Croatia
GlaxoSmithKline

Completed

A Safety Study to Investigate the Skin Irritancy Potential of Diclofenac-Menthol Gel

Pain

United States
Boehringer Ingelheim

Completed

Comparison of the Bioavailability of Diclofenac in a Combination Product (Diclofenac 2% + Capsaicin 0.075% Topical Gel) With Two Diclofenac Only Products, Diclofenac Mono Gel 2% and Voltarol® 12 Hour Emulgel 2.32% Gel, in Healthy Volunteers

Healthy

South Africa
HALEON

Not yet recruiting

A Real-World Evidence Study to Evaluate the Effects of Voltaren Use on Mobility and Quality of Life in Participants With Knee Osteoarthritis Pain

Pain
Javelin Pharmaceuticals

Completed

Study to Compare the Pharmacokinetics of IV Diclofenac Sodium (2 Doses)Versus Oral Diclofenac Potassium

Healthy

United States
Biologische Heilmittel Heel GmbH

Completed

TRAUMED - a Clinical Trial in Acute Ankle Sprain (TRAUMED)

Ankle Sprain

Germany
BDD Pharma Ltd
Drug Delivery International Ltd

Completed

Delayed Release Diclofenac Sodium Formulation vs Voltaren®

Pain

United Kingdom
Fidia Farmaceutici s.p.a.

Completed

Comparative Bioavailability and Local Tolerability of Two Topical Diclofenac Plasters Applied Once and Twice a Day

Bioequivalence Study

Italy
Panineeya Mahavidyalaya Institute of Dental Sciences...

Completed

A Comparative Evaluation of Diclofenac Sodium Transdermal Patch, Oral Diclofenac Sodium With Intramuscular Injections of Diclofenac Sodium in Patients Suffering From Oral Pain

Orofacial Pain

India
Grünenthal GmbH
Grünenthal Colombiana S.A.

Completed

Pharmacokinetic Non-interaction Study With a Fixed-dose Combination Tablet With Tramadol and Diclofenac

Pharmacokinetics

Mexico
Sandoz

Completed

To Demonstrate the Relative Bioavailability of Diclofenac Sodium 75 mg Enteric-Coated Tablets Under Non-Fasting Conditions

Inflammation
Novartis

Completed

Efficacy and Safety of Diclofenac Sodium Gel in Hand Osteoarthritis

Osteoarthritis

France, Germany
Novartis

Completed

Safety of Diclofenac Sodium Gel in Knee Osteoarthritis

Osteoarthritis

United States
Novartis

Completed

Efficacy and Safety of Diclofenac Sodium Gel in Knee Osteoarthritis

Osteoarthritis

United States
Zambon SpA
Cross Research S.A.

Completed

Drug Interaction Study of Safinamide and a BCRP Substrate, Diclofenac, Concomitantly Administered to Healthy Volunteers

Healthy

Switzerland
Joanneum Research Forschungsgesellschaft mbH

Completed

Evaluate the Ability of dOFM for BE Testing of Topically Applied Diclofenac Sodium Products in Healthy Subjects

Healthy

Austria
Novartis

Completed

Efficacy and Safety of Diclofenac Sodium Topical Gel 1% Applied 4 Times Daily in Subjects With Acute Ankle Sprain

Ankle Sprain

United States
Novartis

Completed

Efficacy and Safety of Diclofenac Sodium Gel in Knee Osteoarthritis

Osteearthritis

United States
Taro Pharmaceuticals USA

Completed

A Study Comparing Diclofenac Sodium Gel 3% to Solaraze® Gel 3% in the Treatment of Actinic Keratosis

Actinic Keratosis
Novartis

Completed

A Within-subject Study to Evaluate the Efficacy and Safety of Diclofenac Sodium Topical Gel 1% Compared to Placebo in Subjects Experiencing Delayed Onset Muscle Soreness

Muscle Soreness

United States
Novartis

Completed

Efficacy and Safety of Diclofenac Sodium Gel in Hand Osteoarthritis

Osteoarthritis

United States
Akorn, Inc.

Completed

Bioequivalence Study With Clinical Endpoint for Diclofenac Sodium Topical Gel 1%

Osteoarthritis, Knee

Estonia, Poland, Latvia, Lithuania, Romania, Ukraine
Lotus Clinical Research, LLC
Novartis Pharmaceuticals

Completed

An Investigator Initiated, Within-Subject, Proof of Concept Study to Assess the Efficacy and Safety of Voltaren Gel in Subjects With DOMS

Pain | Delayed Onset Muscle Soreness

United States
Daré Bioscience, Inc.

Active, not recruiting

A Study of Diclofenac Gel in Women With Primary Dysmenorrhea (DARE-PDM1)

Dysmenorrhea Primary

Australia
University of Maryland, Baltimore
Food and Drug Administration (FDA)

Completed

Evaluation of Bioavailability of Diclofenac Dermal Products

Bioavailability

United States
Javelin Pharmaceuticals

Completed

Platelet Function and Safety After IV and Oral Diclofenac, IV Ketorolac and Oral Aspirin in Adult Volunteers

Healthy

United States
Bayero University Kano, Nigeria

Unknown

Intracervical Lidocaine Versus Intramuscular Diclofenac for Pain Relief in HSG in a Tertiary Hospital in Kano

Female Infertility of Tubal Origin

Nigeria
Glenmark Pharmaceuticals Ltd. India

Completed

To Study Generic Diclofenac Sodium Topical Gel 1% in the Treatment of Osteoarthritis of the Knee (Degenerative Joint Disease Presented as Joint Pain, Stiffness, Swelling and Restricted Motion).

Osteoarthritis

United States
FPR Specialty Pharmacy

Unknown

Treatment of Knee Pain With Topical Diclofenac Cream 8% or Diclofenac Gel 1%

Knee Injuries | Knee Pain Chronic

United States
GlaxoSmithKline

Completed

Rosiglitazone Versus a Sulfonylurea On Progression Of Atherosclerosis In Patients With Heart Disease And Type 2 Diabetes

Atherosclerosis

United States, Russian Federation, Spain, Germany, Korea, Republic of, Sweden, Canada, Netherlands, Thailand, Hong Kong, Argentina, France, Mexico, Greece, Poland, Italy, India, Brazil, Latvia, Czech Republic
Cerimon Pharmaceuticals
PPD

Completed

Diclofenac Patch for Treatment of Mild to Moderate Tendonitis or Bursitis

Rotator Cuff Tendonitis | Bicipital Tendonitis | Subdeltoid Bursitis of the Shoulder | Subacromial Bursitis of the Shoulder | Medial Epicondylitis of the Elbow | Lateral Epicondylitis of the Elbow | DeQuervain's Tenosynovitis of the Wrist

United States
Knight Therapeutics (USA) Inc

Withdrawn

Treatment of Leishmaniasis With Impavido® (Miltefosine): Higher-Weight Patient Registry

Leishmaniasis

United States
University of Monastir

Completed

Treatment of Renal Colic in the Emergency Department: Comparison Between Magnesium Sulfate and Lidocaine.

Renal Colic

Tunisia
IBSA Institut Biochimique SA

Completed

Injectable Diclofenac for the Prevention of Post-operative Dental Pain (DP4)

Pain

United Kingdom
Cerimon Pharmaceuticals
PPD

Terminated

Diclofenac Patch for Treatment of Mild to Moderate Ankle Sprain

Ankle Sprain

United States
Fidia Farmaceutici s.p.a.

Completed

Clinical Trial With Diclofenac Sodium Medicated Plaster in Patients With Impact Injuries of the Limbs

Inflammation | Trauma Injury

Hungary, Germany, Italy
Baxalta now part of Shire

Completed

Pharmacokinetic, Safety and Tolerability Study of Recombinant Von Willebrand Factor / Recombinant Factor VIII Complex in Type 3 Von Willebrand Disease

Von Willebrand Disease

United States, Germany, United Kingdom, Italy, Austria, Canada
Cairo University

Completed

Diclofenac Plus Lidocaine Gel for Pain Relief During Intrauterine Device Insertion(IUD).

Pain

Egypt
Children's Hospital of Orange County
CSL Behring

Completed

Clinical Trial of Factor XIII (FXIII) Concentrate

Hemophilia | Factor XIII Deficiency

United States
Iroko Pharmaceuticals, LLC

Completed

Study of Diclofenac Capsules to Treat Pain Following Surgery in Children Ages 6 to <17 Years of Age

Pain, Postoperative

United States
Sandoz

Completed

To Demonstrate the Relative Bioavailability of Diclofenac Sodium 50 mg Enteric-Coated Tablets Under Non-Fasting Conditions

Inflammation
Stichting Hemato-Oncologie voor Volwassenen Nederland
Astellas Pharma Global Development, Inc.; Deutsch-Österreichische Studiengruppe...

Active, not recruiting

A Study of Gilteritinib Versus Midostaurin in Combination With Induction and Consolidation Therapy Followed by One-year Maintenance in Patients With Newly Diagnosed Acute Myeloid Leukemia or Myelodysplastic Syndromes With Excess Blasts-2 With FLT3 Mutations Eligible for Intensive Chemotherapy (HOVON 156 AML)

Acute Myeloid Leukemia | Myelodysplastic Syndrome With Excess Blasts-2

Netherlands, Belgium, Germany, Switzerland, Australia, Finland, Norway, Sweden, Austria, France, Ireland, Lithuania, Luxembourg, Spain
Aljazeera Hospital
Cairo University

Completed

Diclofenac Potassium Alone Versus Diclofenac Potassium With Hyoscine-N-butyl Bromide (HBB in Endoscopy

Pain

Egypt
University of Delaware

Completed

Adverse Neurogenic Actions of Dietary Salt

Blood Pressure

United States

3

Subscribe